Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

2.

Use of thrombopoietic growth factors in acute leukemia.

Kaushansky K.

Leukemia. 2000 Mar;14(3):505-8. Review.

PMID:
10720151
3.

Megakaryocytes and platelets in myeloproliferative disorders.

Briere J, Kiladjian JJ, Peynaud-Debayle E.

Baillieres Clin Haematol. 1997 Feb;10(1):65-88. Review.

PMID:
9154316
5.

Recombinant human thrombopoietin: clinical experience and in vivo biology.

Vadhan-Raj S.

Semin Hematol. 1998 Jul;35(3):261-8. Review.

PMID:
9685172
6.

[Clinical use of recombinant human thrombopoietin. Status and perspectives].

Hansen PB, Hasselbalch HC.

Ugeskr Laeger. 2001 May 7;163(19):2659-62. Review. Danish.

PMID:
11360368
7.

Thrombopoietin in the treatment of acute myeloid leukemia and in stem-cell transplantation.

Linker C.

Semin Hematol. 2000 Apr;37(2 Suppl 4):35-40. Review.

PMID:
10831287
8.

Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.

Newland A.

Semin Hematol. 2007 Oct;44(4 Suppl 5):S35-45. doi: 10.1053/j.seminhematol.2007.11.005. Review.

PMID:
18096471
10.

Clinical approaches involving thrombopoietin to shorten the period of thrombocytopenia after high-dose chemotherapy.

Tijssen MR, van der Schoot CE, Voermans C, Zwaginga JJ.

Transfus Med Rev. 2006 Oct;20(4):283-93. Review.

PMID:
17008166
11.

Bone marrow in megakaryocytic disorders.

Burkhardt R.

Hematol Oncol Clin North Am. 1988 Dec;2(4):695-733. Review.

PMID:
3065325
12.

WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.

Michiels JJ, De Raeve H, Hebeda K, Lam KH, Berneman Z, Schroyens W, Schwarz J.

Leuk Res. 2007 Aug;31(8):1031-8. Epub 2007 Mar 23. Review.

PMID:
17367853
13.

Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS.

Dirnhofer S, Went P, Tichelli A.

Pathobiology. 2007;74(2):115-20. Review.

PMID:
17587882
14.

Recombinant human thrombopoietin: basic biology and evaluation of clinical studies.

Kuter DJ, Begley CG.

Blood. 2002 Nov 15;100(10):3457-69. Review.

15.

Myelofibrosis: experimental models and human studies.

Taskin AL, Cohen-Solal K, Le Couedic JP, Abina MA, Villeval JL, Debili N, Casadevall N, Vainchenker W, Wendling F.

Stem Cells. 1998;16 Suppl 2:155-64. Review.

16.

Etiology of the myeloproliferative disorders: the role of thrombopoietin.

Kaushansky K.

Semin Hematol. 2003 Jan;40(1 Suppl 1):6-9. Review.

PMID:
12682875
17.

Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?

Larson RA.

Best Pract Res Clin Haematol. 2007 Mar;20(1):29-37. Review.

PMID:
17336252
18.
19.

Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.

Kröger N, Damon L, Zander AR, Wandt H, Derigs G, Ferrante P, Demirer T, Rosti G; Solid Tumor Working Party of the European Group for Blood and Marrow Transplantation; German Adjuvant Breast Cancer Study Group; University of California, San Francisco.

Bone Marrow Transplant. 2003 Dec;32(12):1153-7. Review.

PMID:
14647269
20.

[Clonal megakaryocytopathies].

Sánchez Fayos J, Pérez Sáenz M.

Sangre (Barc). 1989 Aug;34(4):259-62. Review. Spanish. No abstract available.

PMID:
2672382

Supplemental Content

Support Center